BamSEC and AlphaSense Join Forces
Learn More

VYNE Therapeutics Inc. – Material Contracts

NASDAQ: VYNE    
Share price (5/28/26): $0.69    
Market cap (5/28/26): $22.9 million

Material Contracts Filter

EX-10.1
from 10-Q 16 pages Tyler Zeronda 33 Hall Rd Chatham Nj 07928 Re: Yarrow Bioscience, Inc. – Employment Offer 2)compensation
12/34/56
EX-10.15
from S-4 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: ● Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. ● Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.14
from S-4 6 pages ​ More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.13
from S-4 16 pages More Terms on Your Offer: Our Offer to You Is Contingent On: ● Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. ● Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.11
from S-4 18 pages Rtw Investments, LP 40 10th Avenue, 7th Floor New York, Ny 10014 WWW.RTWFUNDS.com
12/34/56
EX-10.8
from S-4 15 pages Yarrow Bioscience, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.7
from S-4 13 pages Indemnification Agreement
12/34/56
EX-10.6
from S-4 70 pages Certain Confidential Information Contained in This Document, Marked by [***],Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Registrant Treats as Private or Confidential Exclusive License Agreement by and Between Shanghai Scizeng Medical Technology Co., Ltd. as Licensor and Yarrow Bioscience, Inc. as Licensee and [***] ​ and ​ [***] ​ and ​ [***] ​ And
12/34/56
EX-10.13
from DRS 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.12
from DRS 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.11
from DRS 17 pages Rebecca Frey VELA.BIO@OUTLOOK.com
12/34/56
EX-10.8
from DRS 13 pages Yarrow Bioscience, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.7
from DRS 13 pages Indemnification Agreement
12/34/56
EX-10.6
from DRS 69 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Registrant Treats as Private or Confidential Exclusive License Agreement by and Between Shanghai Scizeng Medical Technology Co., Ltd. as Licensor and Yarrow Bioscience, Inc. as Licensee and [***] and [***] and [***] and [***] as Guarantor
12/34/56
EX-10.1
from 8-K 22 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-10.1
from 425 22 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-10.5
from 8-K 8 pages Form of Lock-Up Agreement
12/34/56
EX-10.5
from 425 8 pages Form of Lock-Up Agreement
12/34/56
EX-10.4
from 425 26 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 26 pages Registration Rights Agreement
12/34/56